Masimo Corp. Stock
Masimo Corp. Stock
The Masimo Corp. stock is trending slightly upwards today, with an increase of €0.000 (0.650%) compared to yesterday's price.
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Masimo Corp..
With a target price of 171 € there is a slightly positive potential of 9.62% for Masimo Corp. compared to the current price of 156.0 €.
Pros and Cons of Masimo Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 0.650% | 1.961% | 1.961% | 4.104% | 40.288% | 7.216% | -10.704% |
| Haemonetics Corp. | 1.540% | 17.094% | 52.902% | - | 0.000% | - | - |
| Bio-Rad Labs Inc. A | -0.080% | -3.951% | 17.037% | 26.085% | -1.978% | -24.807% | -47.113% |
| CONMED Corp. | 0.000% | 11.268% | 1.282% | -39.231% | -9.714% | -73.884% | -71.009% |
Comments
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
On February 17, 2026, Bridger Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Masimo (NASDAQ:MASI).
According to a Securities and
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
Naya Capital Adds Masimo Shares
According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.
Masimo is a leading provider of